Société de Néphrologie Bordeaux  by unknown
Kidney International, Vol. 29 (1986), pp. 775—778
Abstracts
Société de Nephrologe Bordeaux, France
October 18, 1985
Hydrochlorothiazide (lIT) decreases oxalate absorption in calcium
stone formers (CaSF) Bataille F, Finet M, Leflon P. Rogez P. Tn bout B,
Fievet F, Fournier A, CHU, Amiens, France. Effects of HT on oxalate
intestinal absorption was controversial. This may be explained by the
fact that both calcium and oxalate intakes were not well controlled.
Therefore the percent of absorption of oxalate was measured in 21
CaSF after a standard load of I g of oxalate (200 g of spinach) while the
patient was asked to respect a low calcium and low oxalate diet and to
drink the same amount (1.51/d) of water in four conditions: 1) after four
days of hard water (HW: Ca = 11.25; Mg = 2.7 mmole/l) 2) after four
days of soft water (SW: Ca = .25; Mg = .25 mmole/l) 3) after three
months of HW + 50 mg daily of HT 4) after three months of SW + 50
mg daily of HT. Furthermore, the probability of being of a stone former
(Robertson index) was calculated on the basis of UCaV and UOxV on
the 24 hr urine collected before the oxalate load. The results are
summarized for the four therapeutic periods in the table (mean SEM).
The only significant change with HT was the decrease in the percent of
HW
HW+
HT SW
SW+
HT
UCaV 9.2 8.9 4.9 5.3
mmolld
UNaV 185 180 165 190
mmolld
OxV .226 .235 .320 .293
mmolld
UMgV 4.8 5.8 3.6 4.8
mmol/d
UMgIUCa .54 .7 .75 .95
PSF 0.55 .63 .53 .51
%Oxab- 1.2 .5 3.6 2
sorbed ,35a
Significance of the difference with and without HT: ap < 0.02.
oxalate absorbed which decreased with HT both on HW and SW. There
was, however, no significant decrease in calciuria, oxaluria and PSF
related to these factors, nor in magnesium or sodium excretion.
Conclusions: 1) the fact that the long-term hypocalciuric effect of HT is
not shown in this study suggests that the patients were not following
their calcium restricted diet adequately on a long-term basis. 2) This
fact is an explanation for the decrease in oxalate absorption as more
calcium was available for oxalate binding. 3) HT effectiveness would be
therefore explained by a higher tolerance to calcium and oxalate intake,
the actual higher calcium intake inducing no increase in calciuria
because of HT and decreasing the oxalate absorption.
Effects of methylprednisolone (MP) and cyclophosphamide (Cy) on
HgCl2—induced nephritis in the rat Pelletier L, Pasquier R, Vial MC,
Hirsch F, Sapin C, and Druet P, Inserm U28, HôpitalBroussais, 96 rue
Didot, 75674 Paris Cedex 14, France. HgC12 administered to the
Brown—Norway rat causes polyclonal B cell activation resulting in
anti-glomerular basement antibody synthesis, the appearance of circu-
lating immune complexes, and an increase in total serum IgE. The
animals develop glomerulonephritis with marked proteinuria. We
treated BN rats with HgCI2 (0.1 mg/100 g, three times weekly) alone
(A); with Cy (20 mg/kg) on alternate days from day 0 (B); twice weekly
from day 10 (C); or on alternate days from day 15 (D). Five rats (E)
received Cy alone, while five other rats (F) were treated with HgCI2 and
MP (1.5 mg/kg/day from day 0). The parameters monitored were
proteinuria, IgE level measured by ELISA, and renal immunofluores-
cence on days 15 and 60.
%
sur-
vival
%
Protein-
IgE IF
Day
(Day uric 60
Rats 60) rats (*) Day 14 Day 28 Day 15 (L) (G)
A (15) 45 80 10392 973 2256 263 15/15 (++) 12/15
B (6) 100 0 5 4 <1 5/6 (±) 0/6
C (7) 100 0 1208 26 7 0.2 7/7 (+) 0/6
D (5) 100 20 8801 1328 96 46 5/5 (++) 1/4
E (5) 100 0 <1 <1 0/5 0/5
F (5) 80 60 7708 1724 155 17 5/5 (++) 3/3
Abbreviations are: (*) Proteinuna> 30 mg/day; L = linear deposits;
G = granular deposits. These results show that 1) Cy prevents all the
autoimmune abnormalities of HgC12—induced nephritis, 2) Cy cures the
illness when it is administered during the activation phase, and 3) MP is
associated with increased survival but does not prevent the renal
manifestations of the disease.
Immunohistochemical analysis of glomerular extra—cellular roughly
granular material observed in some proliferative glomerulopathies
Guettier C, Hinglais M, Gentric D, Camilleri JP, Bariéty J, Inserm U
28, Hôpital Broussais, Paris, France. A glomerular extra—cellular
roughly granular material (ERGM) has been described in some prolif-
erative glomerulopathies on ultrastructural criteria suggesting a nuclear
origin. ERGM is usually associated with large amounts of C3 and C5b-9
deposits. Thus, the problem was to determine whether ERGM is really
of nuclear origin or is constituted of complement deposits. Fifteen cases
of proliferative glomerulopathies selected for their large ERGM content
were studied by immunofluorescence using anti-C3, anti-C5b-9 antibod-
ies and anti-native DNA serum. ERGM was easily localized because of
its bluish autofluorescence when observed with 390 nm UV light on
frozen and paraffin sections. This autofluorescence, absent in the eight
cases of glomerulopathies with immune deposits or glomerulosclerosis
studied in the same conditions, seem to characterize ERGM. The lack
of superposition of ERUM with staining for C3 and CSb-9 demonstrates
that this material is not complement deposits. No positivity was seen
within ERGM with anti-native DNA serum, but this result does not
eliminate the nuclear origin of ERGM which could be an extremely
degraded material with destruction of many antigenic sites.
Immunocytochemical identification of crescents in diffuse crescentic
glomerulopathies Guettier C, Nochy D, Camilleri JP, Bariéty J, Inserm
U 28, Hopital Broussais, Paris, France. Specific markers for epithelial
cells of Bowman's capsule had not been used in immunocytochemical
analysis of crescents in diffuse crescentic glomerulopathies (DCGN).
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Eight early kidney biopsies from three eases of DCON without immune
deposits, two cases of DCGN with anti-glomerular basement membrane
antibodies and three cases of Wegener's granulomatosis were studied
on serial sections using four monoclonal antibodies: KL1 and KL4
raised against human cytokeratins of 55,000 to 57,000 or 55,000 to
67,000 daltons, and staining exclusively parietal epithelial cells within
normal glomerulus, EBM11 identifying peripheral blood monocytes and
tissular macrophages and OKT3 anti-pan T lymphocytes. Semi-auto-
matic morphometry showed that cellular crescents contained between
24 and 61% anti-keratin positive cells, between 19 and 34% EBM11
positive cells; 12 to 53% cells were negative with the four antibodies. In
each biopsy, epithelial cells of Bowman's capsule outnumbered mac-
rophages within crescents. The composition of crescents did not appear
different in the three types of DCGN. Monocytes/macrophages identi-
fled within crescents by EBM11 were not recognized by us using anti-Ia
antibodies.
Antigliadin antibodies in IgA glomerulonephritis (IgA GN) Branellec
A, Lagrue G, Laurent J, Beighiti D, André C, Intrator L, Bruneau C,
Sainte-Laudy J, Hopital Henri-Mondor Inserm U 139, Créteil, France.
In IgA ON, the pathogenic role of IgA is well documented, but the
specificity of these IgA is unknown, A few cases of eoeliac disease
associated with IgA ON have been reported with remission of the
intestinal and renal manifestations by gluten avoidance. This led us to
investigate the role of an unsuspected gliadin sensitivity in IgA ON. We
measured IgA, IgO and 1gM antibodies to gliadin, /3-lactoglobulin and
ovalbumin by ELISA (solid-phase fluoroenzymatic assay, results ex-
pressed as OD) in 27 unselected primary IgA UN (21 male, 6 female,
mean age 36), 14 membranous ON (MON) (9 male, 5 female, mean age
36) 21 idiopathic nephrotic syndrome (INS) (14 male, 7 female, mean
age 31) and 21 paired normals. The normal value for IgA antigliadin was
less than 650 OD. In IgA ON, 19 of 27 patients had a raised level,
compared to 2 of 14 in MGN and 2 of 21 INS. These differences were
significant (P C 0.001—Mann Whitney Test) between IgA ON and other
groups (MGN, INS, normals). The differences in IgO and 1gM
antigliadin levels were significant between IgA ON and MON and
normals, but not with INS: antigliadin IgO and 1gM were present in half
of INS. Antibodies to g3-lnctoglobulin and ovalbumin were rarely found
and were not more frequent in IgA ON. A cross reactivity with reticulin
was investigated because gliadin and reticulin glycoprotein share com-
mon antigenic determinants. In 17 serum positive for IgA antigliadin, no
reticulin antibodies were detected by immunofluorescense. These re-
suits demonstrate the specificity of antigliadin IgA. This test is of
diagnostic value for distinguishing IgA ON from other UN, with a
sensitivity of 70%, a specificity of 89%, a positive predictive value of
83% and a negative one of 79%. Two interpretations mnst be discussed:
—these antigliadin IgA may be a reflection of high IgA levels in the
serum, but we observed no correlation with IgA levels, and IgA
antibodies to 3-lactoglobulin and ovalbumin were not found.
—these antigliadin IgA may lead to the formation and deposition of
immune complexes in the mesangium: gluten avoidance could correct
the renal abnormalities.
Nephrotic syndrome (NS) and focal and segmeatal glomerulosclerosis
(FGS). Remission Induced by ultrafiltration (UF) Gaudry C, Glorz D,
Dupuy MC, Daniel F, Bariéty J, Druet Ph, Méry J Ph. Hopital
Broussais, 96 rue Didot, 75674 Paris, Centre Pasteur-Vallery-Radot,
Paris, Hdpital Bichat, Paris, France. We treated two markedly
oedematous patients (a 25-year-old man and a 68-year-old woman) with
FSO and NS who were initially steroid-responsive and then
steroid—unresponsive with albumin infusions and UF. This therapy
resulted in polyuria and natriuresis. Other results are indicated below.
In both cases, proteinuria diminished steadily 10 and 20 days after
cessation of UF to levels of two and five g/24 hr three and five months
later, and to the levels indicated above 18 months later. These results
show that UF and albumin infusion were followed by a rapid and
sustained decrease in proteinuria to normal or nearly normal levels.
This suggests that I) hemodynamic factors are responsible for the
persistence of some cases of FSO with NS, and 2) UF by rapid
restoration of perfusion pressure and oncotic pressure transiently
increases glomerular filtration rate. This may account for the initial
discrepancy between serum albumin concentration and proteinuria
noted above.
Case Weight
Prnteinuria
(g/24 hr)
Serum
albumin
(g %)
Creat.
Clearance
(mI/mm)
Patient 1
BefnreUF 90 18 9 110
10 days after
2UF 63 17 19 170
18 mos after UP 66 0 35 120
Patient 2
Before UF 71 12 23 12
10 days after
6UF 61 13 30 20
18 mos after UP 64 0.8 45 21
36 mos after UP 58 0.8 45 20
Food allergy and idiopathic nephrotic syndrome (INS) Lagrue G,
Laurent J, Beighiti D, Sainte-Laudy J, Hópital Henri-Mondor, Creteil,
France. The role of allergy in INS (minimal changes and negative
immunofluorescence) is well documented. Among environmental aller-
gens, pneumallergens have been involved in reported cases. Common
food allergens may also be implicated as demonstrated by Sandberg for
cow's milk by eviction and challenge tests. Nevertheless, their respon-
sibility is not usually sought. We have systemically investigated 34 INS
for sensitization against five food allergens daily ingested in France:
cow's milk, egg, beef, pork and flour. 1) Skin tests and specific 1gB
(RAST) were seldom positive; 2) Human Basophil Degranulation Test
(HBDT) was positive in 22 patients for at least one food and only once
in 19 blood donors (P C 0.01). A definite relationship between food
sensitization and INS (fond allergy) may be only demonstrated by the
results of eviction and tests, performed either by total avoidance
(elemental or oligoantigenic diet) or by specific withdrawal and chal-
lenge as we observed in 4 cases out of 17 corticodependant INS. The
incriminated foods were (I) wheat flour, (2) egg and (1) cow's milk;
long-term food withdrawal (less than one year) lend to complete
remission in spite of discontinuing steroids. But such cases with an
allergy for few foods are rare: polysensitization seems frequent, as in a
22-year-old Chinese patient with corticoresisant INS HBDT was posi-
tive for pork, but specific avoidance had no effect; an oligoantigenic diet
was followed by the disappearance of the proteinuria, with immediate
recurrence when a normal diet was reintroduced. On three occasions
oral administration of Cromoglycate (900 mg/day) was followed by a
significant but transient fall in proteinuria. But Cromoglycate, in other
eases, was seldom efficient (only two remissions out of 14 cases).
In conclusion, hidden food allergy may be responsible for INS and
must be routinely investigated, especially in corticodependant or
corticnresistant forms. HBDT is the more sensitive test to ascertain the
possible implicated foods. An elemental or an oligoantigenic diet or
specific avoidances and specific food challenges, with foods chosen
according to laboratory data (RAST, HBDT) may lead to the disappear-
ance of the proteinuria and a complete remission of INS without steroid
treatment.
Proteinuria, polycythemla during cyanotic congenital heart disease:
Acute and chronic effect of phlebotomies Loute G, Pieters D, Jadot JP,
Bosly A, Moriau M, Nephrology Unit, Centre Hospitalier de Sainte
Ode, Urology Unit, Hopital de Aye, Hematology Unit, University of
Louvain, Brussels, Belgium. A 30-year-old mongoloid man was admit-
ted in January, 1985 for asymptomatic proteinuria.
In 1980, he was treated for pulmonary empyema. At that time,
hemoglobin (Hb) was 22.8 WI, creatinine (Cr) 15.5 mg/I, and urine was
normal.
In 1982 he was admitted for gouty arthritis (uric acid 10.9 mg/I) and
exertional dyspnea. He was treated by allopurinol. A diagnosis of
Eisenmenger's syndrome was made. Hb was 22.5 g/l, Cr 12 mg/I and
urine showed proteinuria at 400 mg/I.
On admission, his clinical and cardiovascular status was unmodified,
renal echography was normal, HB was 22 g/l, Cr was 10.4 mg/I,
creatinine clearance was 78 mI/mm. Proteinuria (1.39 WI) was perma-
nent, isolated and glomerular selective.
Nine serial phlebotomies were performed over three months. Pro-
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teinuria decreased immediately after each phlebotomy and gradually
over three months. Finally, the early morning urine became negative
when Hb was normalized at 14 gIl. Only a minimal orthostatic protein-
uria (0.3 g/l) was still observed. There was no cardiovascular modifica-
tion and creatinine clearance remained at 80 mI/mm.
Several points are discussed: the functional or organic proteinuria;
the immediate effect of each phlebotomy; and the longstanding interest
of a normalized rheology by serial phlebotomies.
Incidence, causes and evolution of renal amyloidosis in a population of
250,000 Simon P, Ramee MP, Ang KS, Cam G, Nephrology unit, La
Beauchée Hospital, Saint Brieuc, and Pathology Laboratory CHU
Rennes, France. Between January 1, 1975 and December 31, 1984,
renal amyloidosis (RA) was diagnosed by renal biopsy in 22 patients (9
male, 13 female), aged from 43 to 77 years (mean, 59 years). All patients
were born and lived in a health district of 250,000 inhabitants. The
incidence was evaluated to one per 100,000 and three per 100 renal
biopsy. Nineteen patients (80%) had one (12 cases) or two (7 cases)
etiological factors; rheumatic disease, 9 (rheumatoid arthritis, 8;
ankylosing arthritis, 1); chronic infectious disease, 15 (tuberculosis, 5;
sinusitis, 5; bronchial dilatation, 3; pyelonephritis, 2); Sjogren's syn-
drome, 1; idiopathic pulmonary fibrosis, 1; myeloma, 1. Amyloidosis
was primary in 3 patients (Bence Jones proteinuria, 3). At the time of
diagnosis, 90% of patients had proteinuria, 60% nephrotic syndrome,
41% renal failure, 2 of whom with ESRF. Histological examination
showed glomerular deposits in 20 of 22, vascular deposits in 18 of 22,
tubular and/or interstitial deposits in 19 of 22. Immunofluorescence
examination showed Ig and/or C3 deposits in 10 of 13. At the end of the
period under review, 11 patients (50%) had died and the mean evolution
time was 11 months (ito 36 months). Death was due to cardiovascular
complication in 7 (63%). Eleven patients were alive with a mean
evolution time of 30 months (2 to 84 months). Five patients began a
treatment by dialysis: 2 died after 8 months and 3 were alive at the end
of the period (8, 10 and 24 months). Hemodialyzed patients with renal
amyloidosis represented 3% of the whole population who began the
hemodialysis treatment during the period under review.
Effect of thromboxane synthetase inhibition on renal function of
patients with peripheral arterial ischemic disease Hornych A, Fiessenger
JN, Housset E, Bariéty J, Hópital Broussais, U-28 Inserm, Paris,
France. The effect of thromboxane synthetase specific inhibition by
Dazoxiben on renal function and urinary excretion of prostaglandins
(PG) and thromboxane B2 (TxB2) was studied in 14 patients with
occlusive peripheral arterial disease. The clinical investigation was
performed in double blind study. All patients were treated 14 days with
Dazoxiben (D) 4 x 200 mg/day and 14 days with placebo (P) in random
order. Results are: 1) urinary PGs. Urinary TxB2 excretion was 180
27 pg/mm in placebo period (Pp) and it decreased to 108 14 pg/mm in
Dazoxiben treatment period (Dp) (P < 0.01, — 40%). Urinary 6-Keto-
PGF1 alfa excretion increased by 50% in Dp, PGE2 excretion by 47%
and POE2 alfa excretion by 21%. The urinary 6-Keto-PGF1s/TxB2 ratio
increased from 0.35 0.08 (Pp) to 0.99 0,26 (Dp) (P < 0.02), the
urinary PGE2/PGF2a ratio did not change. 2) Renal functions The
creatinine clearance was 80 10 mI/mm in Pp and was not significantly
modified by D treatment. However, there was a moderate increase of
natriuresis (+9%) and kaliuresis (+ 16%) in D treatment period. Con-
clusions a) Dazoxiben treatment inhibits significantly urinary TxB2
excretion concomittantly with enhanced excretion of other PGs, b)
Dazoxiben increases significantly the urinary 6-Keto-PGF1a/TXB2 ratio
without the modification of PGE2/PGF2a ratio, which suggests the
preferential consumption of endoperoxides for renal prostacyclin syn-
thesis (considerably decreased in our patients with multiple atheroscle-
rotic lesions).
Hemolytic uremic syndrome (HUS) in a patient on oral contraceptives
Schillinger F, Montagnac R, Birembaut P, Hopfner C, Services de
Néphrologie, Hémodialyse et d'Anatomie Pathologique, CHG Troyes,
France. A 41-year-old woman who had been taking oral contraceptives
for 18 years, except during 4 normal pregnancies, developed hemolytic
anemia (Hb 6.3 g/i00 ml; RBC 2,040,000/mm3; schizocytes 6%;
haptoglobin 38 mg/iOO ml; hemopexin 27.8 mg/iOO ml; high density
bone marrow with erythroid hyperplasia), thrombocytopenia
(56,000/mm3) without intravascular coagulation, severe hypertension
with grade IV retinopathy, and acute renal failure (RF) requiring early
hemodialysis. Percutaneous renal biopsy was performed 20 days later
after recovery of normal platelet count, and typical lesions of
thrombotic microangiopathy were found. The usual etiologic investiga-
tions were negative, but the antisteroid—antibodies are positive for the
progestagen. The evolution was favourable while the patient received
plasma infusions during hemodialysis, calciparin, dipyridamole and
antihypertensive drugs. Dialysis was discontinued after two months.
Eight months later creatinine was 220 mole/l, even though the second
renal biopsy showed persistence of important ischemic lesions. Post-
partum BUS is not rare, but BUS has been reported in only thirty cases
after oral contraceptives or estrogens were taken for durations from two
weeks to ten years. The outcome was always severe: death in half of the
cases, irreversible RF requiring dialysis or transplantation in 12 cases,
residual RF in 4 cases, and only 1 recovery. It is thus essential to avoid
oral contraceptives in women likely to develop BUS, particularly when
they have hypertension, hyperlipemia, a history of thrombosis or
toxemia, and especially anti-estrogen or anti-progestogen antibodies.
Urinary excretion of prostaglandins during hypertension induced by
pregnancy. Relationship with renin—angiotensin system and kinin—kal-
likrein system Fievet P, Agnes E, De Frémont F, Bataille P. Mimram A,
Fournier A, Department of Nephrology, CHU Amiens, Hôpital Tenon,
Paris, CHU Montpellier, France. We measured simultaneously the
urinary excretion of prostaglandins PGE2, PGF2,, 6 keto PGF1,. and
TXB2 in 23 patients with pregnancy—induced hypertension and 16
normotensive pregnant women at the same time of gestation (31 3
weeks). We measured simultaneously urinary excretion of kallikrein,
plasma renin activity and plasma aldosterone. We distinguished two
kinds of hypertension induced by pregnancy according to the response
of blood pressure to home bed rest: permanent hypertension (17
patients) and labile hypertension (6 patients). No difference was ob-
served between the two hypertensive groups and control group for
urinary excretion of prostagiandin except for TXB2 which was found to
be higher in labile hypertension than in permanent hypertension. PRA
was lower in permanent hypertension than in the control group and
higher in labile hypertension than in permanent hypertension and the
control group. Correlation studies of kallikrein showed correlation with
6 keto PGF1 excretion, explained by the physiological stimulation of
phospholipase A2 by kallidin. Correlation studies of PRA disclosed
unexpected negative correlation with PGE2 and 6 keto PGF1. in the
permanent PIH group. Conclusions: 1) Labile PIH has a different
biological profile than permanent PIH since they have higher PRA and
higher TXB2 excretion. 2) Permanent PIH has a dysregulation of the
renin angiotensin—prostacyclin loop since PRA and 6 keto PGF1 are
negatively correlated.
Renin angiotensin aldosterone system and adrenergic system in hyper-
tension induced by pregnancy: Critical role of the stimulative conditions
and of the lability of blood pressure in the assessement of their patho-
physiological role Fievet P. Coevoet B, De Frémont JF, Tribout B,
Dufour F, Bataille P, Comoy E, Fournier A, Department of Nephrol-
ogy, CHU Amiens, Department of Obstetric and Gynecology, CHU
Amiens, Laboratory of Biochemistry, CHU Pitié Salpétrière, Paris,
France, These systems were evaluated in two studies performed in
different conditions of stimulation (basal condition, i.e., blood drawn
through indwelling catheter after 30 mm of lying position; and stimula-
tive conditions, i.e., blood drawn immediately after venipuncture after 5
mm of sitting position), in which the hypertensive patients (blood
pressure more than 140 to 90 mmHg after the 20th week of pregnancy)
were distinguished into permanent and labile hypertension induced by
pregnancy (PIH) according to the response of their blood pressure to
home bed rest. Plasma renin activity (PRA) was lower in permanent
PIH than in control only in basal conditions, and higher in labile than in
permanent in both conditions. Plasma aldosterone was lower in perma-
nent PIH than in labile PIH only in basal conditions. Plasma epineph-
tine and norepinephrine are not different in the three groups in basal
conditions but, in stimulative conditions, are significantly higher in
permanent PIH than in control and labile PIH. In basal conditions, a
negative correlation was found between PRA and the logarithm of
plasma norepinephrine when the 2 hypertensive groups (R = —0.457;N
= 32; P < .01) or when all the three groups (R = —0.414; N = 46; P <
.01) are considered. Conclusions 1.) The conditions of stimulation are
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critical in the evaluation of the role of the adrenergic system which is
unmasked only in stimulative conditions, and of the role of the renin
angiotensin system which is masked on the contrary in the same
stimulative conditions. 2.) The classification of the patients according to
the response of their blood pressure to home bed rest is also important
since permanent hypertension is characterized by a readily reactive
adrenergic system and a low stimulated renin secretion, whereas labile
hypertension is characterized by high renin secretion and normal
adrenergic system. 3.) In PIH there is an unphysiological negative
correlation between PRA and plasma norepinephrine suggesting the
role of a factor simultaneously able to stimulate renin secretion and to
decrease norepinephrine release or vice-versa.
Therapeutical advantage of soft versus hard water in calcium stone
formers (CaSF) treated with hydrochlorothiazide (HT) is dependant upon
conconlittant oxalate restriction Batailie P, Finet M, Renaud H, Leflon
P, Rogez P, TriboutB, Fievet F, FournierA, CHUAmiens, France. HT
and high fluid intake is a well established treatment of nephrolithiasis.
The optimal quality of drinking water however, is a matter of contro-
versy mainly because the calcium and magnesium content are corre-
lated, and the oxalate excretion is inversely correlated to hardness of
the water. To answer the question of which is the optimal water for
CaSF, a hard one (MW: Ca = 11.25 mmole/1; Mg = 2.7 mmul/l) or a soft
one (SW: Ca = 0.25 mmole/1; Mg = 0.25 mmole/l), 21 patients with
CaSF collected their 24 hr urine during two days, while on an otherwise
low calcium and low oxalate diet, and while taking 50 mg/day of MT
successively after three months of HW and after three months of SW
ingestion at a constant daily amount of 1,5. Furthermore, at noon of the
second urine collection they ingested I g of oxalate as 200 g of spinach.
For each urine collection, the probability of there being a stone former
(PSF according to Robertson) linked to calcium and oxalate was
calculated, as well as the Mg/Ca urinary ratio. The results are summa-
rized in the table.
Mean +
5CM
Hard water Soft water
OX- OX load OX- OX load
UCaV
mmole/
day 8.9 8.6 5.3 5
UoxV
mmole/
day .235 .01 .274 .02 .293 0.2** .453 .0311
UMgV
mmole/
day 5.8 .2 5.7 4.8 .5 4.8
UMg/UCa .7 .08 .7 .08 .95 .22** .99 .21
PSF .63 .05 .64 .05 .51 .05* .72 .0511
Significance of the comparisons hard vs. soft water (*P C 0.05,
<0.01) and before versus after ox load (IF cc 0.05, lIP C 0.01).
The PSF was the lowest and the UMg/UCa the highest when SW was
drunk and oxalate restriction observed. However when oxalate load
was given,the PSF was highest with the soft water because a greater
percentage of oxalate was absorbed (2% vs. 0.5%, P C 0.05).Conclu-
s/on; 1) Even under treatment with HT, calciuria is dependent upon
calcium intake. 2) The therapeutic advantage of using a soft water exists
as regards a more optimal UMg/UCa ratio, but as regards the PSF
linked to oxaluria and calciuria, it exists only when oxalate restriction
is strictly observed.
Internal jugular vein cannulation with two sliastle catheters for
hemodlalysis: 16 months' experience Canaud B, Mion C, Department
Néphrologie, Hópital Lapeyronie Montpellier, France. Despite recent
technical progress in percutaneous methods of venous cannulation,
temporary and immediately usable vascular access remains a problem
in the treatment of uremic patients. Even the subclavian route currently
used faces significant morbidity and difficulties in long term use. To
overcome such problems, we developed a method based on the
percutaneous implantation of two highly biocompatible silastic cathe-
ters into one of the internal jugular veins, subcutaneously tunneled (10
to 15 cm) to a skin exit located in the prepectoralis area. From
September 1982 to June 1985, 165 pairs of catheters were implanted in
153 patients (93 males, 60 females; mean age 52.8 15 years; right 139,
left 26). The mean duration of use was 57.3 days/patient (Ito 16 months)
allowing to perform 25 MD sessions per patient (1 to 120 sessions).
Indications were: end stage renal failure (71), temporary vascular
problem in ESRF (31); transfer from peritoneal dialysis (24) and acute
renal failure (39). With a blood flow rate of 296 4 mI/mm (max 480),
the return venous pressure was 150 8 mmHg and recirculation 7.7
0.7%. Urea and creatinine clearances were respectively 183 4 and t5l
3 mI/mm (hollow fiber dialyzer 1.4 M2). The most appreciated
qualities were convenience and comfort. No traumatic complication
was observed. Three skin exit infections (Staph aureus) were accom-
panied by two episodes of bacteremia and were promptly cured. Three
partial thromboses of superior vena cava shown on phlcbography were
successfully treated by urokinase, anticoagulants and catheter removal.
In conclusion, the internal jugular vein cannulation with two silastic
catheters seems to be a new, safe and attractive method for temporary
vascular access for extracorporeal treatment.
Reversible worsening of renal failure during nifedipine therapy Cluzel
F, D'Agrosa MC, Richard A, Alphone JC, Deteix P, Citron B, Baguet
JC, et Ponsonnaille J. Departments of Nephrology and Cardiology,
CHU Clermont-Ferrand, France. Within 24 hr after nifedipine therapy
(10 mg every 6 hr) was begun for non-transmural myocardial infarction
in a 55-year-old man with hypertension and chronic renal failure, renal
function progressively deteriorated (plasma creatinine rose from 2.6 to
4.0 mg/dl), returning to initial levels after nifcdipine discontinuance.
Results of pharmacological experiments of calcium-channel blockers on
intrarenal hemodynamics are not identical from one protocol to an-
other, but one usually notes an increase in sodium and water urinary
excretion, linked to intrarenal vasodilatation, while there is, in most
cases, no significant change in glomerular filtration rate. In the human
except for two reports of immune complexes glomerulonephritis im-
puted to nifedipine, the current record closely resembles the cases
recently reported by Diamond ct al: in four patients with diffuse
arteriolosclerosis and pre-existent chronic renal failure (from various
causes), use of nifedipine was followed by a marked reduction in renal
function that remitted after drug withdrawal. Although the responsibil-
ity of nifedipine is not clearly demonstrated, and whatever the
physiopathology could be (antagonism of calcium channel blockers with
intrarenal hcmodynamic effects of angiotensin II and/or prostaglan-
dins), those reports emphasize the need for careful supervising of renal
function when calcium channel blockers are given to patients with
arteriolosclerosis and pre-existent renal failure.
